Treace Medical Concepts, Inc. (TMCI) Tops Q2 EPS by 1c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $47.39 million versus the consensus estimate of $47.08 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• M&T Bank Corp. (MTB) Tops Q2 EPS by 69c
• Goldman Sachs Double Downgrades Blau Farmaceutica (BLAU3:BZ) to Sell
• Piper Sandler Downgrades Universal Insurance Holdings (UVE) to Neutral